Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.

Autor: Fouquet C; CHU de Bordeaux, Hôpital Pellegrin, Bordeaux, France., Le Rouzic MA; CHU de Nancy, Hôpital Brabois, Vandoeuvre, France., Leblanc T; CHU de Paris, Hôpital Robert Debré, Paris, France., Fouyssac F; CHU de Nancy, Hôpital Brabois, Vandoeuvre, France., Leverger G; CHU de Paris, Hôpital Armand Trousseau, Paris, France., Hessissen L; CHU Souissi, Rabat, Maroc., Marlin S; CHU de Paris, Hôpital Necker-Enfants maladies, Paris, France., Bourrat E; CHU de Paris, Hôpital Saint-Louis, Paris, France., Fahd M; CHU de Paris, Hôpital Robert Debré, Paris, France., Raffoux E; CHU de Paris, Hôpital Saint-Louis, Paris, France., Vannier JP; CHU de Rouen, Hôpital Charles Nicolle, Rouen, France., Jäkel N; Department für Hämatologie, Onkologie und Hämostaseologie, Leipzig, Germany., Knoefler R; Department of Pediatric Haemostaseology, University Hospital Carl Gustav Carus, Dresden, Germany., Triolo V; CHU de Nice, Hôpital Lenval, Nice, France., Pasquet M; CHU de Toulouse, Hôpital des enfants, Toulouse, France., Bayart S; CHU de Rennes, Hôpital Pontchaillou, Rennes, France., Thuret I; CHU de Marseille, Hôpital de la Timone, Marseille, France., Lutz P; CHU de Strasbourg, Hôpital de Hautepierre, Strasbourg, France., Vermylen C; Université Catholique de Louvain, Cliniques universitaires Saint-Luc, Brussels, Belgium., Touati M; CHU de Limoges, Hôpital Dupuytren, Limoges, France., Rose C; CHU de Lille, Hôpital Saint Vincent de Paul, Lille, France., Matthes T; Geneva University Hospital, Hematology Service, Geneva, Switzerland., Isidor B; CHU de Nantes, Hôtel Dieu, Nantes, France., Kannengiesser C; Assistance Publique des Hôpitaux de Paris, Département de Génétique, Hôpital Bichat, Université Paris VII, Paris, France., Ducassou S; CHU de Bordeaux, Hôpital Pellegrin, Bordeaux, France.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2019 Nov; Vol. 187 (4), pp. 530-542. Date of Electronic Publication: 2019 Jul 23.
DOI: 10.1111/bjh.16100
Abstrakt: Congenital sideroblastic anaemia (CSA) is a rare disease caused by germline mutations of genes involved in haem and iron-sulphur cluster formation, and mitochondrial protein biosynthesis. We performed a retrospective multicentre European study of a cohort of childhood-onset CSA patients to explore genotype/phenotype correlations. We studied 23 females and 20 males with symptoms of CSA. Among the patients, the most frequently mutated genes were ALAS2 (n = 10; 23·3%) and SLC25A38 (n = 8; 18·6%), causing isolated forms of microcytic anaemia of varying severity. Five patients with SLC19A2 mutations suffered from thiamine-responsive megaloblastic anaemia and three exhibited the 'anaemia, deafness and diabetes' triad. Three patients with TRNT1 mutations exhibited severe early onset microcytic anaemia associated with thrombocytosis, and two exhibited B-cell immunodeficiency, inflammatory syndrome and psychomotor delay. The prognoses of patients with TRNT1 and SLC2A38 mutations were generally dismal because of comorbidities or severe iron overload. No molecular diagnosis could be established in 14/43 cases. This study emphasizes the frequency of ALAS2 and SLC25A38 mutations and provides the largest comprehensive analysis to date of genotype/phenotype correlations in CSA. Further studies of CSA patients with data recorded in an international registry would be helpful to improve patient management and establish standardized guidelines.
(© 2019 British Society for Haematology and John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: